SOURCES SOUGHT
J -- FACSAria II Flow Cytometer Upgrade
- Notice Date
- 12/4/2014
- Notice Type
- Sources Sought
- NAICS
- 811219
— Other Electronic and Precision Equipment Repair and Maintenance
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA-1142645
- Archive Date
- 12/27/2014
- Point of Contact
- James Scott Rawls, Phone: 8705437540
- E-Mail Address
-
james.rawls@fda.hhs.gov
(james.rawls@fda.hhs.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- MARKET RESEARCH PURPOSES ONLY NOT A REQUEST FOR PROPOSAL OR SOLICITATION This is a sources sought to determine the availability and capability of small businesses to provide an upgrade to an existing instrument. The associated North American Industry Classification System (NAICS) Code is 811219 - Other Electronic and Precision Equipment Repair and Maintenance; Small Business Size Standard is $19.0 million. Part I: General Information (Introduction/Background/Scope) The U.S. Food and Drug Administration (FDA), is conducting market research to support the National Center for Toxicological Research (NCTR), Division of Genetic and Molecular Toxicology (DGMT) requirement to add near-UV and yellow lasers to the current BD Biosciences FACSAria II flow cytometer (Serial No. P07800167) to expand capabilities for analysis of samples from humans, experimental animals, and in vitro cell cultures. DGMT routinely performs flow cytometry analyses and sorting, and there is an immediate need to expand options for using multi-color labeling for identification of low frequency events on the current FACSAria II flow cytometer/sorter. Currently, the FACSAria II has two (2) lasers (488nm blue and 635nm red lasers); however, in order to use novel stains and fluorescent labels with greater efficiency, the cytometer must be equipped with a 375nm near-UV laser (which allows non-distractive analysis of DNA content in viable cells) and with a 561nm yellow laser (which allows use of a new class of fluorophores in labeling analyses and permits precise quantitative analysis of some most useful fluorophores without the need for performing compensation-an additional error-prone post-acquisition data manipulation). The instrument is currently being maintained by the manufacturer, BD Biosciences. Part II: Work Requirements A. Service Requirements At a minimum the Contractor shall: • Install a 375nm near ultra-violet solid state laser. • Install a 561nm yellow solid state laser. • Upgrade FACSDiva 8 software controls for utilizing the two added lasers. • Upgrade Kit Channel DAQ/SCI PCBA Aria III. • Perform all conversion activities on-site with formally trained and certified technicians/engineers, following Original Equipment Manufacturer (OEM) specifications, manuals, and service bulletins, using new OEM parts, components, subassemblies, etc. • Include a minimum of a 1-year parts and labor warranty on the upgrades from the date of acceptance. • Provide records and reports, commensurate with the completion of the upgrade, to the end-user of the equipment, to include a copy of a field service report/ticket identifying the equipment name, manufacturer, model number, and serial number of the equipment (along with any changes in the instrument's pertinent information as a result of the upgrade), a detailed description of the work performed, the test instruments or other equipment used to perform the upgrade, the name(s) and contact information of the technician who performed the upgrade, and for information purposes, the on-site hours expended and parts/components replaced. In addition, the Contractor shall provide a written report to the FDA COR and Contract Specialist, summarizing all warranty repair activities each time warranty repair work is performed. Part III: Supporting Information A. Place of Performance Shall be upgraded at: U.S. Food and Drug Administration 3900 NCTR Rd., Bldg 53A, Rm 219 Jefferson, AR 72079 Vendor shall coordinate upgrade with Project Officer (to be provided with order). B. Period of Performance System upgrade shall be completed within 60 calendar days from date of award. Part III: Instructions to Prospective Respondents Responses to this sources sought shall unequivocally demonstrate respondent capability and prior experience to perform the services. In addition, interested sources may offer cost effective alternatives capable of meeting the requirements listed in Parts I and II above. Though the target audience is small businesses capable of upgrading the equipment, all interested parties may respond. At a minimum, responses shall include the following: • Business name and bio, DUNS number, business address, business website, business size status (i.e., SB, VOSB, SDVOSB, HUBZone SB, 8(a), SDB, WOSB, EDWOSB, LB), point of contact name, mailing address (if different from business address), phone number and email address; • Three (3) years of past performance information for the service of same or substantially similar items, to include date of services, description (should also include technical literature and specifications), dollar value, client name, client address, client point of contact name, client point of contact mailing address (if different from that provided for client), client point of contact phone number, client point of contact email address, and name of the manufacturer (to include DUNS number and size status) if not the respondent; • Descriptive literature, brochures, specifications, marketing material, etc. detailing the nature of the services the responding firm is regularly engaged in providing; • If applicable, identification of the firm's GSA Schedule contract(s) by Schedule number and SINs that are applicable to this requirement; • If a large business, identify the subcontracting opportunities that would exist for small business concerns; • Although this is not a request for quote, informational pricing is encouraged; • The Government encourages any comments and/or suggestions from any interested party, regarding the specifications. While the Government will not respond directly to your comments and/or suggestions; we will consider them as we finalize the specifications in preparation for the forthcoming solicitation. The Government is not responsible for locating or securing any information, not identified in the response. Interested Parties must respond with capability statements which are due in person, by postal mail or email to the point of contact listed below on or before December 12, 2014 by 4:00 PM (Central Time in Jefferson, Arkansas) at the Food and Drug Administration, OC/OA/OAGS, Attn: James "Scott" Rawls, 3900 NCTR Road, Bldg 50/Room 430, HFT‐320, Jefferson, AR 72079‐9502 or email james.rawls@fda.hhs.gov. Reference # FDA-1142645 in all correspondence with the point of contact listed above. Notice of Intent Responses to this sources sought announcement will assist the Government in determining whether this requirement should be set aside for small business, made available to full and open competition or procured through other than full and open acquisition procedures. Disclaimer and Important Notes This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a combined synopsis/solicitation (No. FDA-1142645) may be published via FedBizOpps. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-1142645/listing.html)
- Place of Performance
- Address: U.S. FDA/NCTR, 3900 NCTR Rd., Bldg 53A, Rm 219, Jefferson, Arkansas, 72079, United States
- Zip Code: 72079
- Zip Code: 72079
- Record
- SN03587196-W 20141206/141204234619-b26d4c29fe2f50dce164b439635c45cc (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |